Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient-preferred vs physician-prescribed insulin glargine titration in type 2 diabetes
ChiCTR2100050805Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Start
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Second Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Fasting Blood Glucose. Started Dec 2021; status: recruiting.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2100050805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050805.